SEC Form 4 research
| Issuer | Protagonist Therapeutics, Inc |
|---|---|
| Tickers | PTGX |
| Reporting owners | 34 |
| Officers and directors | 16 |
| Last public filing | 2026-10-02 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-02 | 2026-09-30 | Ali Asif | S | 46,034 | $141.78 | Not reported |
| 2026-10-02 | 2026-09-30 | Ali Asif | S | 12,595 | $141.77 | Not reported |
| 2026-09-10 | 2026-09-10 | PATEL DINESH V PH D | S | 7,278 | $144.1 | Not reported |
| 2026-09-10 | 2026-09-09 | PATEL DINESH V PH D | S | 63,548 | $146.18 | Not reported |
| 2026-09-10 | 2026-09-08 | PATEL DINESH V PH D | S | 54,174 | $145.87 | Not reported |
| 2026-08-12 | 2026-08-11 | PATEL DINESH V PH D | S | 34,239 | $148.52 | Not reported |
| 2026-08-12 | 2026-08-10 | PATEL DINESH V PH D | S | 65,761 | $149.11 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.